Bioversys AG (BIOV) — Financial Flexibility Index
Bioversys AG (BIOV) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of CHF-21.73 Million (operating CF CHF-21.95 Million minus capex CHF216.00K) represents -1% of total liabilities (CHF30.82 Million). Check BIOV tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bioversys AG Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Bioversys AG across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Bioversys AG.
Annual Financial Flexibility Index for Bioversys AG (2024–2025)
Year-by-year free cash flow to debt coverage for Bioversys AG. Explore debt repayment capacity of Bioversys AG to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | CHF-21.73 Million | CHF-21.95 Million | CHF30.82 Million | ▼ -10.1% |
| 2024 | -0.64x | CHF-15.54 Million | CHF-15.57 Million | CHF24.27 Million | — |